Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing
Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing
复制标题
通过全外显子组测序对中国家族性阿尔茨海默病患者进行突变筛查
DOI:
10.1016/j.neurobiolaging.2018.11.024
复制
发表时间:
2019-04-01
影响因子:
4.2
通讯作者:
Wu, Zhi-Ying
中科院分区:
文献类型:
--
作者:
Jiang, Bin;Zhou, Jiong;Wu, Zhi-Ying
Familial Alzheimer's disease (FAD) is characterized by a positive family history of dementia and typically occurs at an early age with an autosomal dominant pattern of inheritance. Amyloid precursor protein (APP), presenilin1 (PSEN1), and presenilin2 (PSEN2) are the major causative genes of FAD. The spectrum of mutations in patients with FAD has been investigated extensively in the Caucasian population but rarely in the Chinese population. Here, we performed whole-exome sequencing in a total of 15 unrelated Chinese patients with FAD. Among them, 12 were found to carry missense variants in APP, PSEN1, and PSEN2. Two novel variants (APP: p.D244G, p.K687Q), 3 variants not previously associated with FAD (APP: p.T297M, p.D332G; PSEN1: p.R157S), and 7 previously reported pathogenic variants (APP: p.V717I; PSEN1: p.M139I, p.T147I, p.L173W, p.F177S, p.R269H; PSEN2: p.V139M) were identified. The novel variant APP p.K687Q was classified as likely pathogenic, and the other 4 variants (APP: p.D244G, p.T297M, p.D332G; PSEN1: p.R157S) were classified as uncertain significance. Therefore, APP, PSEN1, and PSEN2 mutations account for 2 (25.0%), 5 (62.5%), and 1 (12.5%) of the genotyped cases positive for mutations, respectively. Furthermore, the genotype-phenotype correlations were described. Our findings broaden the genetic spectrum of FAD with APP, PSEN1, and PSEN2 variants. (C) 2018 Elsevier Inc. All rights reserved.